Denali Therapeutics Company
Denali Therapeutics is a biotechnology company.
Industry:
Biotechnology, Genetics, Health Diagnostics, Therapeutics
Headquarters:
San Francisco, California, United States
Founded Date:
2015
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
8
Total Funding:
347000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2016
Last Funding Type:
Series B
Register and Claim Ownership